Medical Device Firms Faced Increased FDA Scrutiny in 2012
Anson Connected Health Director Scott Thiel to Speak at MedTech Innovate Seminars in Philadelphia on June 19
Anson Compliance Director Scott Durlacher to lead Testing & Quality and Materials Selection Workshops at OrthoTec 2013 on June 4th
FDA has issued a new draft guidance entitled "Glass Syringes for Delivering Drug and Biological Products: Technical Information to Supplement International Organization for Standardization (ISO) Standard 11040-4."  The document can be viewed at  http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM346181.pdf
Biosimilars Expert Gregory Davis, Ph.D., Joins Anson Group

Regulatory Compliance Consulting for Medical
Product Companies

The Anson Group is a regulatory consulting firm that provides clients with strategic advice, planning, and execution services for navigating the federal and global regulatory requirements of life science and medical technology, delivered by qualified, experienced, and knowledgeable industry experts.

Anson offers commercialization and compliance services for companies developing and marketing medical products in the areas of Drugs and Biologics, Medical Devices, Combination Products, and Connected Health Technology. Anson’s business model,  employees, and extensive network of highly specialized contractors can provide world-class experience and knowledge in all aspects of regulatory matters unique to medical technology and life science products.

Anson delivers every client engagement focused on the goal of ensuring that its regulatory strategic recommendations and actions align and support the client’s business strategy.

Do you think FDA will publish Clinical Decision Support Software in 2012?

View Results

Loading ... Loading ...

October 9, 2012

FDA Notice Effective October 1, 2012

+ READ MORE  |  RSS